FDA halts use of monoclonal antibodies that don't work against Omicron - and Florida pushes back
FDA halts use of monoclonal antibodies that don't work against Omicron - and Florida pushes back
Briefly

from Cbsnews 2 years ago

COVID-19 antibody drugs from Regeneron and Eli Lilly should no longer be used because they don't work against the Omicron variant that now accounts for nearly all U.S. infections, U.S. health regulators said Monday.

Read at Cbsnews

[

]

[

...

]

FDA halts use of monoclonal antibodies that don't work against Omicron - and Florida pushes backFDA halts use of monoclonal antibodies that don't work against Omicron - and Florida pushes back Briefly

FDA halts use of monoclonal antibodies that don't work against Omicron - and Florida pushes back
FDA halts use of monoclonal antibodies that don't work against Omicron - and Florida pushes back
Briefly